Cellectis
CLLS
86 hedge funds and large institutions have $319M invested in Cellectis in 2018 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 30 increasing their positions, 13 reducing their positions, and 9 closing their positions.
200% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 9
131% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 13
44% more capital invested
Capital invested by funds: $222M → $319M (+$96.9M)
25% more funds holding
Funds holding: 69 → 86 (+17)
7.15% more ownership
Funds ownership: 19.63% → 26.78% (+7.2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
58% less call options, than puts
Call options by funds: $1.38M | Put options by funds: $3.33M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$26.1M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$25.3M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$19.3M |
| 4 |
BlackRock
New York
|
+$9.54M |
| 5 |
NC
Nexthera Capital
New York
|
+$6.42M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$9.45M |
| 2 |
AC
Ascend Capital
Orinda,
California
|
-$3.91M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$1.94M |
| 4 |
JP Morgan Chase
New York
|
-$1.93M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.13M |
CLLS Hedge Fund Activity: Q2 2018 in Review
86 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q2 2018, worth a combined $319M — up 44% from $222M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new CLLS positions and 9 closed out — a net gain of 18 holders — while 30 added to existing stakes and 13 trimmed.
The largest buyer was Capital World Investors, opening a new position worth an estimated $26.1M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $9.45M sold.
- 86 institutional investors held Cellectis (CLLS) as of Q2 2018, up from 69 in Q1 2018.
- Funds reported $319M of Cellectis stock for Q2 2018, up 44% quarter-over-quarter.
- 27 funds opened new Cellectis positions in Q2 2018 and 9 closed out, a net change of +18 holders.
- The largest Cellectis buyer in Q2 2018 was Capital World Investors, an estimated $26.1M added.
- The largest Cellectis seller in Q2 2018 was Perceptive Advisors, an estimated $9.45M sold.
Based on aggregated 13F filings for Q2 2018.